supp.fit

Phosphatidylserine

11 benefits mapped to clinical evidence across supplements.

Dose per serving from products

1,015 products in our catalogue print how much Phosphatidylserine a serving holds.

Most common: 50 mg to 100 mg, 41% of 1,015 products.

Dose per servingProducts
5 mg or less
35
5 mg to 10 mg
53
10 mg to 25 mg
116
25 mg to 50 mg
206
50 mg to 100 mg
415
100 mg to 250 mg
127
250 mg to 500 mg
49
over 500 mg
14

Dose per serving from research

22 study groups in 17 studies say how much Phosphatidylserine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 50% of 22 study groups.

Daily doseStudy groups
50 mg to 100 mg
4
100 mg to 250 mg
6
250 mg to 500 mg
11
over 500 mg
1

See every study group

Benefit Evidence

Memory + cognition

EEG/glucose metabolism

Fatty acids/neurotransmitters

1,599 people
Memory
Moderate

Memory tests +

Recall/working memory +

ADHD memory +

1,506 people

Cognition +

Memory/ADL +

1,503 people

Attention/memory +

Reactivity/recall -118ms

550 people
Mood balance
Moderate

Mood/fatigue + stress

PMS/cortisol + distress

858 people
Learning
Moderate

Memory tests improved

+1.1 recall

n-3 PUFAs/neurotransmitters up

600 people

Lower cortisol/ACTH

Stress response ↓

Blunted cortisol +4.87

292 people

Cortisol/stress ↓

Mood/fatigue ↓

HOMA‑IR −1.1

272 people

Memory/cognition +0.7

Neurochemistry/metabolism +0.4

332 people

Fitness/endurance +25%

BP/VO2max +3.7

103 people

Memory tests + MQ

Perceived fatigue lower

102 people

Research sources

Brain health (12)
  1. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial

    PubMed ID: 23495677

    Randomized, placebo-controlled trial in children with ADHD showed clinically meaningful improvements in core symptoms and short-term memory with soy-derived PS.

  2. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation

    PubMed ID: 8038871

    Randomized study in AD demonstrating early cognitive and EEG/metabolism changes with PS+training supports overall cognitive benefit, though effects waned.

  3. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

    PubMed ID: 8239307

    Direct human trial in AD showing increased regional glucose metabolism and improved cognitive test performance early with PS+training—strong evidence for cognitive support (short-term).

  4. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration

    PubMed ID: 8323999

    Large RCT in elderly demonstrated cognitive and behavioral improvements with PS.

  5. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type

    PubMed ID: 1633433

    Early dementia trial reported clinical global improvement and EEG normalization with PS.

  6. Effects of phosphatidylserine in Alzheimer's disease

    PubMed ID: 1609044

    Bovine cortex PS improved some cognitive tests in probable AD.

  7. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia

    PubMed ID: 25414047

    Review/compilation of RCTs and PK studies showing repeated cognitive and functional stabilization signals with soy PS+PA.

  8. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial

    PubMed ID: 20523044

    Randomized PS‑DHA trial showed significant immediate verbal recall benefit in non‑demented elderly.

  9. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study

    PubMed ID: 24577097

    Open‑label PS‑DHA in elderly demonstrated improvement/maintenance of cognitive measures across 15 weeks.

  10. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids

    PubMed ID: 18469236

    Phospholipid‑bound n‑3 intervention (including PS carrier) improved biochemical incorporation and sustained attention in children with attention problems, supporting cognitive outcomes.

  11. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Double‑blind randomized trial of a Mg‑L‑threonate + PS formula showed broad, significant cognitive and memory improvements in healthy adults.

  12. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    Large 12‑month RCT in MCI using a PS‑containing multi‑nutrient supplement improved multiple cognitive measures versus placebo.

Memory (10)
  1. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial

    PubMed ID: 23495677

    Soy-derived PS (200 mg/day) for 2 months improved short-term auditory memory in children with ADHD vs placebo—direct memory benefit.

  2. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    12‑month RCT in MCI with a PS‑containing multi‑nutrient supplement improved short‑term memory and other cognitive measures versus placebo.

  3. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Randomized double‑blind trial of a PS‑containing Magtein® formula produced significant gains on multiple memory tests and overall memory quotient.

  4. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study

    PubMed ID: 24577097

    Open‑label PS‑DHA improved sustained attention and memory recognition in previously untreated elderly with memory complaints.

  5. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial

    PubMed ID: 20523044

    PS‑DHA randomized trial improved immediate verbal recall in non‑demented elderly (direct PS formulation evidence).

  6. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia

    PubMed ID: 25414047

    Compilation of trials showed repeated signals of improved/stabilized memory and ADLs with soy PS+PA formulations.

  7. Effects of phosphatidylserine in Alzheimer's disease

    PubMed ID: 1609044

    Bovine cortex PS improved some cognitive scores in probable AD, especially milder cases.

  8. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration

    PubMed ID: 8323999

    Large multicenter RCT in elderly showed memory and behavioral improvements with 300 mg/day PS.

  9. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

    PubMed ID: 8239307

    In AD patients PS+training increased cognitive test performance and regional brain glucose uptake early in treatment—supports memory improvements short-term.

  10. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation

    PubMed ID: 8038871

    Randomized study showed early neuropsychological improvements with PS+training that waned by 6 months—some memory benefit early on.

Healthy aging (10)
  1. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration

    PubMed ID: 8323999

    Large multicenter RCT in elderly showed cognitive and behavioral improvements with 300 mg/day PS over 6 months.

  2. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    12‑month RCT in MCI patients using a PS‑containing multi‑nutrient supplement produced clinically meaningful cognitive improvements and biochemical changes relevant to brain health.

  3. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Magtein® formula with PS improved cognitive performance in healthy adults, with larger gains in older participants — consistent with support for brain aging.

  4. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study

    PubMed ID: 24577097

    Open‑label PS‑DHA study in elderly with memory complaints showed maintenance/improvements in attention/recognition over 15 weeks.

  5. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial

    PubMed ID: 20523044

    PS‑DHA improved immediate recall in non‑demented elderly—direct evidence relevant to brain aging.

  6. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia

    PubMed ID: 25414047

    Compilation of human studies documented absorption and repeated signals of memory/ADL/mood stabilization with soy PS+PA in elderly and AD.

  7. Effects of phosphatidylserine in Alzheimer's disease

    PubMed ID: 1609044

    Bovine cortex PS improved cognitive tests in probable AD, larger benefit in less severe cases.

  8. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type

    PubMed ID: 1633433

    300 mg/day PS produced clinical global improvements and EEG normalization in early dementia.

  9. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

    PubMed ID: 8239307

    In AD patients PS+training increased task-related cerebral glucose uptake and improved cognitive scores early—supports short-term symptomatic benefit in aging brain.

  10. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation

    PubMed ID: 8038871

    Randomized AD trial showed early cognitive/EEG/glucose metabolism improvements with PS+training, though effects faded over 6 months.

Focus & concentration (6)
  1. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial

    PubMed ID: 23495677

    PS improved core ADHD symptoms (inattention/impulsivity) and auditory working memory—strong evidence for improved focus in this pediatric sample.

  2. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

    PubMed ID: 8239307

    Neuropsychological performance improvements in PS+training AD trial include attention-related measures early in treatment.

  3. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study

    PubMed ID: 24577097

    Open‑label PS‑DHA study reported improvements in sustained attention in elderly with memory complaints.

  4. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids

    PubMed ID: 18469236

    Randomized trial using EPA/DHA esterified to phospholipids (including PS carrier) produced greater improvement in sustained visual attention (TOVA) than fish oil or placebo.

  5. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Broad cognitive improvements in the RCT of a PS‑containing product included attention‑related test gains consistent with improved focus.

  6. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    MCI study with PS‑containing supplement improved several cognitive domains including attention‑related measures.

Mood balance (4)
  1. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia

    PubMed ID: 25414047

    Compilation reported mood improvements/stabilization in elderly and AD patients with soy PS+PA.

  2. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration

    PubMed ID: 8323999

    Behavioral improvements in the large elderly trial indicate mood/behavior stabilization.

  3. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial

    PubMed ID: 29576358

    PAS (PS+PA) reduced PMS symptom scores including mood symptoms over three cycles—direct mood stabilization evidence.

  4. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress

    PubMed ID: 15512856

    PS+PA reduced subjective distress during acute stress, indicating mood stabilization under stress.

Learning (4)
  1. The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial

    PubMed ID: 41318468

    Sunflower PS improved visuospatial learning in underperforming children (subgroup effect).

  2. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial

    PubMed ID: 20523044

    PS‑DHA improved immediate recall and learning measures in non‑demented elderly (esp. higher baseline cognition).

  3. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Multi‑domain cognitive gains in a randomized trial using a PS‑containing formula indicate improved learning/learning‑related memory performance.

  4. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    MCI RCT with PS‑containing supplement improved several cognitive subtests that relate to learning capacity.

Stress resilience (4)
  1. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial

    PubMed ID: 30796508

    Curcumin‑phosphatidylserine phytosome lowered serum cortisol versus placebo in an 8‑week RCT, indicating reduced HPA axis activation.

  2. Untitled

    PubMed ID: 22575036

    High‑chronic‑stress subgroup experienced restored cortisol responses and stress reduction with omega‑3 PS.

  3. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress

    PubMed ID: 15512856

    400 mg PS+PA clearly blunted ACTH and cortisol responses to the Trier Social Stress Test and reduced subjective distress.

  4. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study

    PubMed ID: 25081826

    PAS400 reduced ACTH and cortisol responses in chronically stressed men—robust endocrine evidence in subgroup.

Stress & Anxiety (4)
  1. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial

    PubMed ID: 30796508

    Curcumin‑PS phytosome lowered serum cortisol in an RCT, which commonly correlates with reductions in perceived stress.

  2. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial

    PubMed ID: 29576358

    PMS symptoms (including emotional/stress aspects) were reduced with PAS.

  3. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study

    PubMed ID: 25081826

    Chronically stressed men on PAS400 showed reduced perceived chronic stress and lower cortisol responses.

  4. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress

    PubMed ID: 15512856

    Subjects on 400 mg PS+PA reported decreased subjective distress during an acute psychosocial stressor.

Mental clarity (3)
  1. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

    PubMed ID: 39317299

    12‑month RCT in MCI with a multi‑nutrient product containing PS improved several cognitive test scores (arithmetic, similarity, short‑term memory).

  2. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

    PubMed ID: 8239307

    Short-term cognitive test improvements in AD patients receiving PS+training suggest clearer cognitive function early in treatment.

  3. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    30‑day randomized trial of Magtein® formula (contains PS) produced robust improvements across multiple cognitive/memory tests consistent with enhanced clarity.

Workout performance (2)
  1. New Nutraceutical Combination Reduces Blood Pressure and Improves Exercise Capacity in Hypertensive Patients Via a Nitric Oxide-Dependent Mechanism

    PubMed ID: 32078787

    Multi‑ingredient nutraceutical that included PS improved VO2 and exercise tolerance in hypertensive patients.

  2. Interval aerobic/resistance exercise training depresses adrenergic-induced apoptosis of lymphocytes in sedentary males

    PubMed ID: 37712975

    Six weeks of interval training (physiology study) improved aerobic capacity and muscle endurance; not a PS supplement trial but shows context where PS biology was measured.

Energy & Fatigue (1)
  1. A Magtein(ÂŽ), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults

    PubMed ID: 36558392

    Cognitive improvements in the 30‑day RCT may reflect reduced cognitive fatigue, though direct fatigue measures were not the primary endpoint.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Phosphatidylserine

Search all

1741 products whose verified label declares Phosphatidylserine — not every bottle that mentions it in a title.

Being studied right now

Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.